Journal of Bone and Mineral Research

Association of Dietary Niacin Intake With Incident Hip Fracture, BMD, and Body Composition: The Cardiovascular Health Study 2019

Cost-Effectiveness of Osteoporosis Screening Using Biomechanical Computed Tomography for Patients With a Previous Abdominal CT 2019

Glucocorticoid Exposure and Fracture Risk in a Cohort of US Patients With Selected Conditions.  33:1881-1888. 2018

Specificity Protein 7 Is Required for Proliferation and Differentiation of Ameloblasts and Odontoblasts.  33:1126-1140. 2018

Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial.  33:763-772. 2018

Prevalence of Osteoporosis and Low Bone Mass Among Puerto Rican Older Adults.  33:396-403. 2018

The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial.  32:2278-2287. 2017

Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward.  32:424-430. 2017

Impact of Competing Risk of Mortality on Association of Weight Loss With Risk of Central Body Fractures in Older Men: A Prospective Cohort Study.  32:624-632. 2017

The Association Between Protein Intake by Source and Osteoporotic Fracture in Older Men: A Prospective Cohort Study.  32:592-600. 2017

Novel Genetic Variants Associated With Increased Vertebral Volumetric BMD, Reduced Vertebral Fracture Risk, and Increased Expression of SLC1A3 and EPHB2.  31:2085-2097. 2016

Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS).  31:1810-1819. 2016

What Proportion of Incident Radiographic Vertebral Fractures in Older Men Is Clinically Diagnosed and Vice Versa: A Prospective Study.  31:1500-1503. 2016

Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women.  31:1466-1472. 2016

Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study.  30:2086-2095. 2015

Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus.  30:3-23. 2015

Loss of Runx2 in committed osteoblasts impairs postnatal skeletogenesis.  30:71-82. 2015

The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine.  29:2520-2526. 2014

Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: The global longitudinal study of osteoporosis in women (GLOW).  29:487-493. 2014

Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American society for bone and mineral research.  29:1-23. 2014

Risk factors for treatment failure with antiosteoporosis medication: The global longitudinal study of osteoporosis in women (GLOW).  29:260-267. 2014

Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation.  29:2653-2665. 2014

A close examination of healthcare expenditures related to fractures.  28:816-820. 2013

A randomized trial of a mailed intervention and self-scheduling to improve osteoporosis screening in postmenopausal women.  27:2603-2610. 2012

Recent trends in hip fracture rates by race/ethnicity among older US adults.  27:2325-2332. 2012

Energy expenditure and bone formation share a common sensitivity to AP-1 transcription in the hypothalamus.  27:1649-1658. 2012

Serum response factor regulates bone formation via IGF-1 and Runx2 signals.  27:1659-1668. 2012

Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes.  27:858-864. 2012

Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women.  27:645-653. 2012

Predicting fractures in an international cohort using risk factor algorithms without BMD.  26:2770-2777. 2011

Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: The women's health initiative (WHI).  26:2378-2388. 2011

Stronger bone correlates with African admixture in African-American women.  26:2307-2316. 2011

Erratum: Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research (Journal of Bone and Mineral Research (2010) 25 (2267-2294)).  26:1987. 2011

Nucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activators.  26:1913-1925. 2011

APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner.  26:1084-1098. 2011

The relationship between bisphosphonate adherence and fracture: Is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial.  26:683-688. 2011

Lower bone mass in prepubertal overweight children with prediabetes.  25:2484-2493. 2010

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research.  25:2267-2294. 2010

Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines.  25:1506-1511. 2010

Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis.  25:1295-1304. 2010

Candidate gene analysis of femoral neck trabecular and cortical volumetric bone mineral density in older men.  25:330-338. 2010

Ferritin ferroxidase activity: A potent inhibitor of osteogenesis.  25:164-172. 2010

Serum 25-hydroxyvitamin D and the risk of hip and nonspine fractures in older men.  25:545-553. 2010

Health care expenditures associated with skeletal fractures among medicare beneficiaries, 1999-2005.  24:2050-2055. 2009

High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.  24:2039-2049. 2009

Myeloma bone disease.  24:1783-1788. 2009

Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis.  24:1643-1646. 2009

Bridging the osteoporosis quality chasm.  24:3-7. 2009

Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the women's health initiative hormone intervention trials.  23:1935-1945. 2008

A Runx2 Threshold for the Cleidocranial Dysplasia Phenotype..  23:S384-S384. 2008

Benefit of adherence with bisphosphonates depends on age and fracture type: Results from an analysis of 101,038 new bisphosphonate users.  23:1435-1441. 2008

Induction of Runx2 and Osterix by Bisphosphonate Promote Osteogenic Differentiation.  23:S257-S257. 2008

Calcium channel TRPV6 is involved in murine maternal-fetal calcium transport.  23:1249-1256. 2008

HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE.  23:1084-1096. 2008

Longitudinal trends in use of bone mass measurement among older Americans, 1999-2005.  23:1061-1067. 2008

Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling.  23:596-609. 2008

Doubly truncated FosB isoform (Δ2ΔFosB) induces osteosclerosis in transgenic mice and modulates expression and phosphorylation of Smads in osteoblasts independent of intrinsic AP-1 activity.  23:584-595. 2008

Genetic and pharmacologic activation of the hypoxia inducible factor pathway promotes angiogenesis and accelerates bone regeneration.  22:S19-S19. 2007

Growth inhibition of osteoblast progenitors by Runx2 depends on its C-terminal regulatory domain and is accompanied by changes in G-Protein coupled signaling pathways.  22:S94-S94. 2007

Krüppel-like zinc finger protein Glis3 promotes osteoblast differentiation by regulating FGF18 expression.  22:1234-1244. 2007

Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene.  22:274-285. 2007

Predictors of non-spine fracture in elderly men: The MrOS study.  22:211-219. 2007

Defects in intranuclear localization of Runx2 alter osteoblast differentiation ex vivo..  21:S155-S155. 2006

Mitotic retention of the bone phenotype by the cell fate determining transcription factor Runx2..  21:S378-S378. 2006

Post-mitotic expression of transcription factor RUNX2 defines a novel regulatory transition during the G1 phase of proliferating Pre-Osteoblasts..  21:S384-S384. 2006

Specific residues of Runx2/Cbfa1 direct Osteoblast differentiation and integration of BMP2 osteogenic signal..  21:S381-S381. 2006

Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: Results from the women's health initiative randomized trial.  21:817-828. 2006

RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.  20:107-116. 2005

RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity.  20:1858-1866. 2005

A critical point mutation in the Runx2 subnuclear targeting domain abrogates osteogenic function by blocking integration of the BMP2 signal.  20:S9-S9. 2005

Inactivation of Nek1 protein kinase signaling in Kat2J mice leads to skeletal defects..  20:S40-S40. 2005

Microarray analysis of differential gene expression in OSCC cell lines..  20:S213-S213. 2005

Msx2 antagonizes Runx2 regulation of osteolytic activity in breast cancer cells..  20:S327-S327. 2005

Reconstitution of Runx2/Cbfa1null cells identifies Runx2 domains required for osteoblast differentiation.  20:S5-S5. 2005

Runx2 association with microtubules: A potential role in nucleo-cytoplasmic shuttling..  20:S78-S78. 2005

The Runx2 transcription factor supports expression of genes coupled to the invasive and osteolytic properties of breast cancer cells..  20:S328-S328. 2005

Comparative effect of soy protein, soy isoflavones, and 17β-estradiol on bone metabolism in adult ovariectomized rats.  20:828-839. 2005

Contributions of nuclear structure-function relationships to the onset and progression of tumorigenesis.  20:P7-P7. 2005

Expression patterns of matrix metalloproteinases and vascular endothelial growth factor during epiphyseal ossification.  20:1011-1021. 2005

RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts..  20:107-116. 2005

Runx2 regulates tumor cell invasive properties and contributes to the osteolytic bone disease associated with metastatic cancer cells.  20:P16-P16. 2005

Runx2/Msx2 interactions regulating breast cancer-induced osteolysis in bone.  20:P33-P33. 2005

Convergence of BMP2/TGF beta MAPK and Runx2 signaling in subnuclear foci during osteogenic lineage induction.  19:S46-S46. 2004

Dlx3 is a transcriptional regulator of osteoblast differentiation and increases expression and promoter activity of Runx2..  19:S37-S37. 2004

Establishment of a mechanistic link between the osteogenic function of Runx2 and its sulnuclear organization by intranuclear informatics..  19:S144-S144. 2004

Expression pattern of core binding factor-beta in skeletal tissues.  19:S400-S400. 2004

Multiple nuclei in osteoclasts functionally compartmentalize gene regulatory machinery.  19:S280-S281. 2004

Wnt signaling regulates Runx2 expression in vivo and activates the bone-related Runx2 P1 promoter.  19:S56-S56. 2004

Ectopic Runx2 regulates breast cancer metastasis-associated osteolytic disease.  19:1578-1578. 2004

Chromatin remodeling of the proximal rat osteocalcin promoter is dependent on vitamin D receptor binding at the distal promoter element.  18:S225-S225. 2003

Ectopic runx2 regulates breast cancer metastasis associated osteolytic disease.  18:S26-S26. 2003

Subnuclear targeting supports functional interrelationships between Runx2 and the BMP-2 regulated Smad 1 protein.  18:S6-S7. 2003

Radioguided Parathyroidectomy for Recurrent Hyperparathyroidism Caused by Forearm Graft Hyperplasia.  18:939-942. 2003

Cbfb, a well-known, regulator of hematopoiesis, cooperates with Cbfa1 and plays a critical role in bone development..  17:S126-S126. 2002

Runx factors are expressed in the osteoclast and regulated during osteoclast differentiation..  17:S452-S452. 2002

Runx1(Cbfa2/AML1) is expressed in tissues supporting osteogenesis and temporally regulated during chondrocyte and osteoblast differentiation..  17:S151-S151. 2002

Genome screen for quantitative trait loci contributing to normal variation in bone mineral density: The Framingham study.  17:1718-1727. 2002

Radioguided parathyroidectomy via VATS combined with intraoperative parathyroid hormone testing: The surgical approach of choice for patients with mediastinal parathyroid adenomas?.  17:1368-1371. 2002

Developmental utilization of distinct promoters regulating the type I and type II isoforms of the bone Runx2/Cbfa1 transcription factor..  16:S205-S205. 2001

Forced expression of Runx2/Cbfa1 driven by the -3.6 kb Collagen Type I promoter results in a normal phenotype in transgenic mice..  16:S446-S446. 2001

Runx2-C/EBP molecular interactions and functional synergism support maximal expression of osteocalcin in osteoblasts..  16:S175-S175. 2001

Trafficking of Runx1/Cbfa2 and Runx2/Cbfa1 in living cells defines a dynamic subnuclear domain..  16:S488-S488. 2001

Acidic fibroblast growth factor signaling inhibits peroxynitrite-induced death of osteoblasts and osteoblast precursors.  16:1917-1925. 2001

The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis.  16:1754-1764. 2001

Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats.  16:1682-1687. 2001

C/EBP is a potent activator of osteocalcin gene transcription..  15:S497-S497. 2000

In vivo replacement of the Runx2/Cbfa1 gene with a mutant gene lacking a subnuclear targeting signal and transcriptional regulatory functions results in severe skeletal abnormalities..  15:S157-S157. 2000

RUNX (CBFalpha/AML/PEBP2alpha) dependent repression of tissue-specific gene transcription involves in situ association with Groucho/TLE/R-esp proteins..  15:S498-S498. 2000

Rapid epiphyseal trabecular bone resorption in high-dose corticosteroid treatment correlates with osteocytic apoptosis and passive tetracycline uptake, while cytokine expression patterns in vitro implicate an alternative osteoclast induction mechanism..  15:S542-S542. 2000

C/EBP family members are expressed in osteoblast and are involved in regulation of osteocalcin gene transcription..  14:S469-S469. 1999

Cbfa family members act as a negative regulator of the bone sialoprotein gene..  14:S165-S165. 1999

Contributions of nuclear architecture to bone-specific and steroid hormone regulation of osteocalcin gene transcription..  14:S454-S454. 1999

Resorption and microfractures precede vascular changes in subarticular bone with high-dose glucocorticoid treatment..  14:S547-S547. 1999

Structure-function determinants for subnuclear targeting and transactivation in the Cbfa1/AML3 transcription factor..  14:S469-S469. 1999

The C-terminus of CBFA1 supports subnuclear trafficking of green fluorescent protein tagged-CBFA1..  14:S553-S553. 1999

Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.  12:1570-1576. 1997

Expression of nitric oxide synthase isoforms in bone and bone cell cultures.  12:1108-1115. 1997

The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density.  12:1049-1057. 1997

A comparative immunocytochemical study on the subcellular distributions of 44 kDa bone phosphoprotein and bone γ‐carboxyglutamic acid (Gla)‐containing protein in osteoblasts.  2:337-346. 1987

Mechanism of fibroblast attachment to bone extracellular matrix: Role of a 44 kilodalton bone phosphoprotein.  2:259-265. 1987